Prime medicine, inc.PRME.US Overview
US StockHealthcare
(No presentation for PRME)
PRME Overall Performance
PRME AI Analysis & Strategy
PRME Recent Performance
-0.45%
Prime medicine, inc.
0.81%
Avg of Sector
-1.14%
S&P500
PRME PowerScanner
PRME Key Information
PRME Valuation Metrics
PRME Earnings Table
PRME Profile
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.